TY - JOUR
T1 - BubR1 alterations that reinforce mitotic surveillance act against aneuploidy and cancer
AU - Weaver, Robbyn L.
AU - Limzerwala, Jazeel F.
AU - Naylor, Ryan M.
AU - Jeganathan, Karthik B.
AU - Baker, Darren J.
AU - van Deursen, Jan M.
N1 - Funding Information:
We thank Liviu Malureanu, for initiating the project and the members of the van Deursen lab for helpful discussions and feedback. We thank Qianqian Guo for animal breeding and genotyping. This work was supported by grants from the National Institutes of Health: RMN (F30 CA189339) and JMvD (R01 CA096985 and R01 CA126828).
Publisher Copyright:
© Weaver et al.
PY - 2016/8/16
Y1 - 2016/8/16
N2 - BubR1 is a key component of the spindle assembly checkpoint (SAC). Mutations that reduce BubR1 abundance cause aneuploidization and tumorigenesis in humans and mice, whereas BubR1 overexpression protects against these. However, how supranormal BubR1 expression exerts these beneficial physiological impacts is poorly understood. Here, we used Bub1b mutant transgenic mice to explore the role of the amino-terminal (BubR1N) and internal (BubR1I) Cdc20- binding domains of BubR1 in preventing aneuploidy and safeguarding against cancer. BubR1N was necessary, but not sufficient to protect against aneuploidy and cancer. In contrast, BubR1 lacking the internal Cdc20-binding domain provided protection against both, which coincided with improved microtubule-kinetochore attachment error correction and SAC activity. Maximal SAC reinforcement occurred when both the Phe- and D-box of BubR1I were disrupted. Thus, while under- or overexpression of most mitotic regulators impairs chromosome segregation fidelity, certain manipulations of BubR1 can positively impact this process and therefore be therapeutically exploited.
AB - BubR1 is a key component of the spindle assembly checkpoint (SAC). Mutations that reduce BubR1 abundance cause aneuploidization and tumorigenesis in humans and mice, whereas BubR1 overexpression protects against these. However, how supranormal BubR1 expression exerts these beneficial physiological impacts is poorly understood. Here, we used Bub1b mutant transgenic mice to explore the role of the amino-terminal (BubR1N) and internal (BubR1I) Cdc20- binding domains of BubR1 in preventing aneuploidy and safeguarding against cancer. BubR1N was necessary, but not sufficient to protect against aneuploidy and cancer. In contrast, BubR1 lacking the internal Cdc20-binding domain provided protection against both, which coincided with improved microtubule-kinetochore attachment error correction and SAC activity. Maximal SAC reinforcement occurred when both the Phe- and D-box of BubR1I were disrupted. Thus, while under- or overexpression of most mitotic regulators impairs chromosome segregation fidelity, certain manipulations of BubR1 can positively impact this process and therefore be therapeutically exploited.
UR - http://www.scopus.com/inward/record.url?scp=84983087695&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84983087695&partnerID=8YFLogxK
U2 - 10.7554/eLife.16620.001
DO - 10.7554/eLife.16620.001
M3 - Article
C2 - 27528194
AN - SCOPUS:84983087695
SN - 2050-084X
VL - 5
JO - eLife
JF - eLife
IS - AUGUST
M1 - e16620
ER -